CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway

CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway

BackgroundRadioresistance poses a major therapeutic challenge in ESCC, significantly impacting patient prognosis. CD9, as a crucial membrane regulatory protein, exhibits dual regulatory roles in various cancers, yet its precise mechanism in ESCC radioresistance remains unclear. This study aims to sy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liubing Hou, Zengyao Hao, Ge Zhang, Jiayuan Li, Yu Wang, Xiaoying Xue, Huandi Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Oncology
Subjects:	esophageal squamous cell carcinoma radioresistance prognostic biomarker CD9 Akt/GSK3β pathway
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1625120/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Implication of CCNG1 in radiosensitivity via the Wnt/β-catenin pathway in esophageal squamous cells
by: Yuxiang Zhang, et al.
Published: (2024-11-01)

Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation
by: Nico Hartmann, et al.
Published: (2022-06-01)

MYO1B promotes radioresistance in head and neck squamous cell carcinoma by regulating tumor stemness and DNA damage repair via the PI3K/AKT pathway
by: Yanan Li, et al.
Published: (2025-07-01)

USP14 inhibition by degrasyn induces YAP1 degradation and suppresses the progression of radioresistant esophageal cancer
by: Fang Yuan, et al.
Published: (2025-02-01)

Brusatol Inhibits Esophageal Squamous Cell Carcinoma Tumorigenesis Through Bad-Mediated Mitochondrial Apoptosis Induction and Anti-Metastasis by Targeting Akt1
by: Yao Ji, et al.
Published: (2025-06-01)

TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway
by: Liqiang Shi, et al.
Published: (2025-04-01)

RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
by: Zijian Da, et al.
Published: (2025-06-01)

Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway
by: Zhibin Liu, et al.
Published: (2025-06-01)

GAS reduced inflammatory responses in activated microglia by regulating the Ccr2/Akt/Gsk-3β pathway
by: Haolong Shi, et al.
Published: (2025-05-01)

Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma
by: Ben Sang, et al.
Published: (2019-12-01)

A VAT1-related gene signature predicts radioresistance in gliomas
by: Xia Shan, et al.
Published: (2025-02-01)

Type of course of schizophrenia and polymorphisms of neuronal protein kinase genes on the model of PIP5K2A, GSK3B and AKT1
by: E. G. Poltavskaya, et al.
Published: (2019-12-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Establishment and biological characterization of radioresistant colorectal cancer cell lines
by: Tian‐Yin Qu, et al.
Published: (2025-06-01)

MODERN RADIOTHERAPY REGIMENS AND BIOMARKERS OF RADIORESISTANT RECTAL TUMOR CELLS
by: N. G. Vasilchenko, et al.
Published: (2020-01-01)

Alkannin Induces G2/M-Phase Arrest, Apoptosis, and Inhibition of Invasion by Targeting GSK3β in Esophageal Squamous Cell Carcinoma
by: Ma H, et al.
Published: (2024-11-01)

Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1
by: Bensi Zhang, et al.
Published: (2025-08-01)

The role of squamous cell carcinoma antigen and cytokeratin 19 fragment in predicting the outcome of esophageal cancer patients: insights from a meta-analysis
by: Xiaojiang Zhou, et al.
Published: (2025-04-01)

Apigenin ameliorates CCl4-induced hepatic fibrosis by inhibiting hepatic stellate cell activation via PI3K/AKT/GSK3β pathway in mice
by: Tao Sun, et al.
Published: (2025-04-01)

Radioresistant mouse pheochromocytoma cell lines
by: Sandy Lemm, et al.
Published: (2025-07-01)

Expression of kinetochore component NDC80 promotes esophageal squamous cell carcinoma cells proliferation and migration
by: Youwu Shi, et al.
Published: (2025-06-01)

Modified ZhuJing pill protects retinal pigment epithelium against oxidative stress-induced epithelial–mesenchymal transition through Nrf2-mediated Akt/GSK3β pathway
by: Ning Yang, et al.
Published: (2025-05-01)

BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation
by: Jialu Xu, et al.
Published: (2025-01-01)

Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response
by: Mengjie Che, et al.
Published: (2025-09-01)

Therapeutic effects of chitosan/β-glycerophosphate/collagen hydrogel combined with MSCs on chronic achilles tendon injury via the Akt/GSK-3β pathway
by: Songlin Liu, et al.
Published: (2025-02-01)

MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review
by: Massimo Meco, et al.
Published: (2025-07-01)

Identification and exploration of key genes associated with radioresistance in lung adenocarcinoma
by: Ying Wang, et al.
Published: (2025-04-01)

Zuojin Pill inhibits the proliferation of esophageal cancer cells by inducing ROS production and apoptosis via regulation of PI3K/Akt signalling
by: Lingyu Wang, et al.
Published: (2024-12-01)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in patients with cirrhosis and esophageal varices
by: Tomoaki Mochimaru, et al.
Published: (2023-04-01)

The Shengmai San Exerts Therapeutic Effects on Type 2 Diabetes by Modulating the PI3K/AKT/GSK3B Signaling Pathway
by: Shang H, et al.
Published: (2025-04-01)

Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling
by: Jia‐cheng Xu, et al.
Published: (2025-06-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)

Corrigendum: Comparative analysis of the development of acquired radioresistance in canine and human mammary cancer cell lines
by: Mark Gray, et al.
Published: (2025-05-01)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
by: Dae Gon Ryu, et al.
Published: (2025-03-01)

Chemo-immunotherapy sequential with radiotherapy in advanced or metastatic esophageal squamous cell carcinoma
by: Xiang Han, et al.
Published: (2025-12-01)

cIAP-2 protein is upregulated by human papillomavirus in oropharyngeal cancers: role in radioresistance in vitro
by: Carolina Oliva, et al.
Published: (2024-09-01)

ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01)

Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma
by: Kexi Wang, et al.
Published: (2024-12-01)

Cerasus humilis Proanthocyanidins Ameliorats Insulin Resistance through PI3K-Akt-GSK-3β Signaling Pathway in HepG2 Cells
by: Xinhui LIU, et al.
Published: (2025-04-01)